Показано 0 из 0
Дата |
---|
08.05.2024 |
07.05.2024 |
06.05.2024 |
03.05.2024 |
02.05.2024 |
01.05.2024 |
30.04.2024 |
29.04.2024 |
26.04.2024 |
25.04.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
4.20
|
4.37
|
4.45
|
4.20
|
4.665
|
4.27
|
|
|
313 188.59
|
699.00
|
4.16
|
4.36
|
3.89
|
3.89
|
4.245
|
4.245
|
|
|
153 209.60
|
502.00
|
3.61
|
4.12
|
3.90
|
3.85
|
3.96
|
3.89
|
|
|
91 116.71
|
369.00
|
3.62
|
3.95
|
4.05
|
3.82
|
4.12
|
3.825
|
|
|
149 584.99
|
590.00
|
3.75
|
4.00
|
3.80
|
3.70
|
4.01
|
3.94
|
|
|
283 299.66
|
678.00
|
3.74
|
3.90
|
3.46
|
3.385
|
3.79
|
3.745
|
|
|
222 837.62
|
612.00
|
3.25
|
3.79
|
3.52
|
3.35
|
3.52
|
3.39
|
|
|
78 900.72
|
367.00
|
3.36
|
3.55
|
3.48
|
3.48
|
3.66
|
3.50
|
|
|
108 222.55
|
326.00
|
3.42
|
3.78
|
3.49
|
3.38
|
3.53
|
3.425
|
|
|
81 222.69
|
329.00
|
3.27
|
3.49
|
3.40
|
3.32
|
3.46
|
3.425
|
|
|
73 599.38
|
326.00
|
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis platform, XpressCF.